# White Label Clinical Trials Listing - Tool: White Label Solutions - Last updated: July 2026 ## TL;DR No white-label clinical trials listing product exists — this is a regulated data-and-recruitment problem, not a rebrandable SaaS category. HIPAA governs participant health data; 21 CFR Part 11 governs electronic consent; IRB oversight applies to recruitment materials. Genuine healthcare white-label engines (DocVilla, blueBriX, Blaze.tech) are EHR tools — none is a trials platform. The only real path is custom-built on a HIPAA-compliant foundation. ## Frequently asked questions ### How much does a white-label clinical trials listing platform cost? There is no white-label clinical trials listing product to license. The only viable path is a custom build. A compliant listing and pre-screening MVP costs $13,000–$25,000 fixed with RapidDev. Full 21 CFR Part 11 system validation and IRB-coordinated consent workflows are additional regulatory professional-services work quoted separately after a scoping call — these can add substantially to total cost depending on the regulated scope of your trials. ### How fast can I launch a branded clinical trials listing platform? Software development takes 6–10 weeks. The regulatory phases run in parallel and often take longer: IRB review cycles run 4–12 weeks per submission, BAA execution with subprocessors takes 2–3 weeks, and 21 CFR Part 11 system validation (if required) requires documented validation protocols that add weeks. Realistically, plan for a 3–6 month timeline from project start to compliant go-live. ### What regulations apply to a clinical trials listing platform? HIPAA applies to any collection of participant health information during pre-screening. 21 CFR Part 11 applies to electronic records and signatures used in FDA-regulated clinical studies — including digital consent signatures. IRB oversight applies to recruitment materials and consent forms. GDPR applies for EU-based trial participants. These are not optional depending on the use case — if your platform collects health information from prospective participants for regulated studies, all of the above apply. ### Do I own participant data on a custom-built trials listing platform? Yes, if you build on infrastructure you control. Participant consent records and pre-screening health data are regulated PHI — but on a custom build with HIPAA-compliant hosting (Blaze.tech, HIPAA Vault, or AWS HIPAA-eligible services) configured under your account, you own and control the data. Contrast this with any enterprise SaaS platform where participant data is in the vendor's system and subject to their export and termination terms. ### Can I build a clinical trials listing platform on ClinicalTrials.gov data? Yes. ClinicalTrials.gov provides a public API (clinicaltrials.gov/api) with open access to registered trial data. You can integrate this into a custom platform to power searchable trial listings. The integration requires data-quality validation logic — raw registry data includes incomplete, out-of-date, and closed-enrollment records that need filtering before display to participants. Sponsor-private trial data requires direct data-sharing agreements with individual sponsors beyond what the public API provides. ### Can RapidDev build a custom clinical trials listing platform? Yes. RapidDev builds custom clinical trials listing platforms in 6–10 weeks for $13,000–$25,000 fixed — including ClinicalTrials.gov integration, eligibility pre-screening questionnaires, HIPAA-compliant participant data handling, referral routing with status tracking, and a sponsor and CRO portal. The fixed price covers the compliant listing MVP. Full 21 CFR Part 11 system validation and IRB-coordinated consent workflows are scoped separately based on your specific regulatory requirements. Book a free scoping call at rapidevelopers.com. ### What is the difference between a clinical trials listing platform and a clinical trial management system (CTMS)? A clinical trials listing platform is participant-facing: it aggregates public and sponsor-provided trial records, helps prospective participants find matching trials, runs pre-screening questionnaires, captures consent, and routes referrals to site coordinators. A CTMS is site-facing: it manages the operational conduct of a trial — protocol tracking, subject enrollment and visit scheduling, adverse event reporting, and regulatory document management. These are adjacent but distinct systems; many research organizations need both, and they can share participant data via API. --- Source: https://www.rapidevelopers.com/white-label/clinical-trials-listing © RapidDev — https://www.rapidevelopers.com/white-label/clinical-trials-listing